Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: Break Through Cancer
Legal name: Commonwealth Cancer Consortium Inc
EIN 85-1681659 · Snapshot of IRS recognition, filing currency, financial health, and governance.
Break Through Cancer is a foundation dedicated to supporting translational research in the most difficult to treat cancers. Our partner organizations are among the top Cancer research centers and together, represent some of the most brilliant, creative minds in the country. We believe Break Through Cancer is the beginning of a scientific movement that accepts nothing less than multi-institutional collaboration in patient centric Cancer research. The foundation will work closely with teams of scientists, engineers, and clinical researchers to focus on diagnosing, treating, and ideally curing some of the most intractable forms of Cancer. While many patients have benefited from advances in research and technology, there are far too many who have been left behind. There are too many cancers where the needle remains unmoved. Break Through Cancer is committed to making headway in these extremely complex, challenging diseases, and committed to finding hope for patients and their families.
Principal Officer
William Hulme
Total Revenue
$13.4M
FY2024
Total Expenses
$28.7M
FY2024
Net Assets
$55.9M
Program Ratio
91.3%
expenses on programs
Employees
28
Volunteers
0
Board Members
14
Voting
10
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.